[HTML][HTML] Nanoparticles and nanomaterials-based recent approaches in upgraded targeting and management of cancer: a review
A Ojha, S Jaiswal, P Bharti, SK Mishra - Cancers, 2022 - mdpi.com
Simple Summary According to the International Agency for Research on Cancer (IARC), in
2018, the global burden of cancer is expected to grow to 27.5 million new cancer cases by …
2018, the global burden of cancer is expected to grow to 27.5 million new cancer cases by …
Nanoparticles and Nanomaterials-Based Recent Approaches in Upgraded Targeting and Management of Cancer: A Review
A Ojha, S Jaiswal, P Bharti, SK Mishra - Cancers, 2022 - pubmed.ncbi.nlm.nih.gov
Along with the extensive improvement in tumor biology research and different therapeutic
developments, cancer remains a dominant and deadly disease. Tumor heterogeneity …
developments, cancer remains a dominant and deadly disease. Tumor heterogeneity …
[HTML][HTML] Nanoparticles and Nanomaterials-Based Recent Approaches in Upgraded Targeting and Management of Cancer: A Review
A Ojha, S Jaiswal, P Bharti, SK Mishra - Cancers, 2023 - ncbi.nlm.nih.gov
Along with the extensive improvement in tumor biology research and different therapeutic
developments, cancer remains a dominant and deadly disease. Tumor heterogeneity …
developments, cancer remains a dominant and deadly disease. Tumor heterogeneity …
Nanoparticles and Nanomaterials-Based Recent Approaches in Upgraded Targeting and Management of Cancer: A Review
A Ojha, S Jaiswal, P Bharti, S Mishra - Cancers, 2022 - europepmc.org
Along with the extensive improvement in tumor biology research and different therapeutic
developments, cancer remains a dominant and deadly disease. Tumor heterogeneity …
developments, cancer remains a dominant and deadly disease. Tumor heterogeneity …
Nanoparticles and Nanomaterials-Based Recent Approaches in Upgraded Targeting and Management of Cancer: A Review
A Ojha, S Jaiswal, P Bharti, SK Mishra - Cancers, 2023 - search.proquest.com
Along with the extensive improvement in tumor biology research and different therapeutic
developments, cancer remains a dominant and deadly disease. Tumor heterogeneity …
developments, cancer remains a dominant and deadly disease. Tumor heterogeneity …
Nanoparticles and Nanomaterials-Based Recent Approaches in Upgraded Targeting and Management of Cancer: A Review.
A Ojha, S Jaiswal, P Bharti, SK Mishra - Cancers, 2023 - search.ebscohost.com
Abstract Simple Summary: According to the International Agency for Research on Cancer
(IARC), in 2018, the global burden of cancer is expected to grow to 27.5 million new cancer …
(IARC), in 2018, the global burden of cancer is expected to grow to 27.5 million new cancer …
Nanoparticles and Nanomaterials-Based Recent Approaches in Upgraded Targeting and Management of Cancer: A Review.
A Ojha, S Jaiswal, P Bharti, SK Mishra - Cancers, 2022 - europepmc.org
Along with the extensive improvement in tumor biology research and different therapeutic
developments, cancer remains a dominant and deadly disease. Tumor heterogeneity …
developments, cancer remains a dominant and deadly disease. Tumor heterogeneity …